Dr. Hossein Borghaei graduated medical school from Philadelphia College of Osteopathic Medicine and completed his residency program at Graduate Hospital. A fellowship in hematology/oncology followed at Temple University Hospital. Dr. Borghaei is both specialized and board certified in medical oncology. He has been in practice for more than 11 years and is affiliated with the Temple University Hospital. During his career, he had run several clinical trials and had also published multiple writings of medical interest in collaboration with other doctors.
Philadelphia College of Osteopathic Medicine Graduated in 1996
Medical School
Philadelphia College of Osteopathic Medicine Completed in 1997
Internship
Graduate Hospital-Tenet Healthcare
Residency
Temple University Hospital
Fellowship
American Board of Internal Medicine
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer
Borghaei H, Alpaugh K, Hedlund G, Forsberg G, Langer C, Rogatko A, Hawkins R, Dueland S, Lassen U, Cohen RB
See more >>Induction of adaptive Anti-HER2/neu immune responses in a Phase 1B/2 trial of 2B1 bispecific murine monoclonal antibody in metastatic breast cancer
Borghaei H, Alpaugh RK, Bernardo P, Palazzo IE, Dutcher JP, Venkatraj U, Wood WC, Goldstein L, Weiner LM
See more >>Overcoming the KRAS resistance mechanism by augmenting antibody-dependent cellular cytotoxicity
Hossein Borghaei, Barry Jones, Chris Kiritsy, Jack H Lai and William Bachovchin
See more >>American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
National Comprehensive Cancer Network